BioNTech SE (BNTX)
107.04
+4.90
(+4.80%)
USD |
NASDAQ |
Nov 21, 14:49
BioNTech Market Cap: 25.66B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 24.49B |
| November 19, 2024 | 25.51B |
| November 18, 2024 | 24.42B |
| November 15, 2024 | 23.91B |
| November 14, 2024 | 24.83B |
| November 13, 2024 | 26.73B |
| November 12, 2024 | 25.49B |
| November 11, 2024 | 26.07B |
| November 08, 2024 | 26.52B |
| November 07, 2024 | 25.86B |
| November 06, 2024 | 25.57B |
| November 05, 2024 | 26.60B |
| November 04, 2024 | 26.12B |
| November 01, 2024 | 26.73B |
| October 31, 2024 | 27.11B |
| October 30, 2024 | 27.32B |
| October 29, 2024 | 27.33B |
| October 28, 2024 | 27.15B |
| October 25, 2024 | 26.49B |
| October 24, 2024 | 26.79B |
| October 23, 2024 | 26.61B |
| October 22, 2024 | 26.58B |
| October 21, 2024 | 26.75B |
| October 18, 2024 | 26.80B |
| October 17, 2024 | 27.44B |
| Date | Value |
|---|---|
| October 16, 2024 | 28.23B |
| October 15, 2024 | 28.18B |
| October 14, 2024 | 28.80B |
| October 11, 2024 | 28.89B |
| October 10, 2024 | 28.38B |
| October 09, 2024 | 28.16B |
| October 08, 2024 | 28.84B |
| October 07, 2024 | 29.14B |
| October 04, 2024 | 29.41B |
| October 03, 2024 | 28.72B |
| October 02, 2024 | 28.53B |
| October 01, 2024 | 28.75B |
| September 30, 2024 | 28.47B |
| September 27, 2024 | 28.11B |
| September 26, 2024 | 27.97B |
| September 25, 2024 | 27.53B |
| September 24, 2024 | 28.17B |
| September 23, 2024 | 26.88B |
| September 20, 2024 | 26.70B |
| September 19, 2024 | 26.75B |
| September 18, 2024 | 27.49B |
| September 17, 2024 | 29.65B |
| September 16, 2024 | 29.36B |
| September 13, 2024 | 29.34B |
| September 12, 2024 | 24.97B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.463B
Minimum
Nov 21 2019
108.46B
Maximum
Aug 09 2021
31.26B
Average
26.49B
Median
Oct 25 2024
Market Cap Benchmarks
| Novavax Inc | 1.303B |
| DBV Technologies SA | 48.10M |
| Akari Therapeutics PLC | 14.94M |
| Biodexa Pharmaceuticals PLC | 2.468M |
| NuCana PLC | 2.875M |
Market Cap Related Metrics
| PS Ratio | 7.822 |
| Price to Book Value | 1.202 |
| Price to Free Cash Flow | 25.06 |
| Price | 107.04 |
| Earnings Yield | -1.98% |